Affordability and Accessibility The Nu.Q Vet Cancer Test is described as affordable, accessible, and easy to use, positioned for routine screening in older dogs during annual wellness checks. This creates a sales opportunity with general veterinary clinics and pet owners seeking proactive cancer screening and early detection.

Global Reach Product availability in over 20 countries suggests a scalable distribution model and potential for international partnerships, distributors, and multi-national veterinary networks to expand adoption and drive recurring test volumes.

Collaborative Validation Development in collaboration with Texas A&M University and dissemination through leading conferences and peer-reviewed journals adds credibility with veterinarians, enabling targeted outreach to academically inclined clinics and research-oriented practices.

Complementary Offering Nu.Q Vet Cancer Test can serve as a complementary screening tool within annual wellness programs and for at-risk breeds, enabling vet practices to upsell screening alongside standard checkups and differentiate from competitors.

Strategic Partnerships Recent and ongoing news mentions collaborations and broader VolitionRx strategic initiatives in blood tests and NETosis-related diagnostics, presenting opportunities to cross-sell or bundle related diagnostic panels to veterinary clients and channel partners.